April 1, 2026 marks Dr. Sanjay Ahuja’s first day as CEO & Medical Director of Innovative Hematology. As we look ahead, our focus now is clear: to build on the strong foundation already in place, strengthen the continuity of care our patients depend on, and position IHI for thoughtful and sustainable growth. Watch his message.
Respiratory Virus Guidance
The following guidelines remain in place at Innovative Hematology to reduce the spread of illness for patients and caregivers.



